Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Low Back Pain Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
20 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Adult males/Females aged over 20 years
Patient with low back pain who needs analgesic administration
Patient with low back pain Who correspond with Class 1, 2 in Quebec Task Force Classification
Pain VAS Value over 40 mm
Subjects who voluntarily or legal guardian agreed with written consent
Patients with severe GI tract disorder, liver disease, renal disease, heart disease, hypertension
Patients with obvious secondary cause(metastatic cancer, fracture, infectious disease)
Patients who had taken back surgery within 24 weeks from the screening point
Patients who had taken opioid drug, psychotropic drug within 4 weeks from the screening point
Patients who had taken steroid drug(oral, injection) within 4 weeks from the screening point